Elevance Health, Inc. (NYSE:ELV) Increases Dividend to $1.72 Per Share

Elevance Health, Inc. (NYSE:ELV) announced a quarterly dividend on Tuesday, January 27th. Stockholders of record on Tuesday, March 10th will be given a dividend of 1.72 per share on Wednesday, March 25th. This represents a c) dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date is Tuesday, March 10th. This is a 0.6% increase from Elevance Health’s previous quarterly dividend of $1.71.

Elevance Health has increased its dividend by an average of 0.2%annually over the last three years and has increased its dividend every year for the last 14 years. Elevance Health has a dividend payout ratio of 17.4% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Elevance Health to earn $39.05 per share next year, which means the company should continue to be able to cover its $6.84 annual dividend with an expected future payout ratio of 17.5%.

Elevance Health Price Performance

ELV traded up $19.09 during trading on Wednesday, reaching $342.01. 3,766,649 shares of the stock were exchanged, compared to its average volume of 1,664,593. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.56 and a quick ratio of 1.56. The company has a market capitalization of $76.01 billion, a price-to-earnings ratio of 13.98, a P/E/G ratio of 1.94 and a beta of 0.51. Elevance Health has a 1 year low of $273.71 and a 1 year high of $458.75. The business’s 50 day moving average price is $350.06 and its two-hundred day moving average price is $328.78.

Elevance Health (NYSE:ELV) last released its quarterly earnings data on Wednesday, January 28th. The company reported $3.33 EPS for the quarter, topping the consensus estimate of $3.10 by $0.23. Elevance Health had a net margin of 2.84% and a return on equity of 16.17%. The business had revenue of $49.31 billion for the quarter, compared to analyst estimates of $49.52 billion. During the same period in the previous year, the firm earned $3.84 EPS. The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. Elevance Health has set its FY 2026 guidance at 25.500- EPS. As a group, equities research analysts anticipate that Elevance Health will post 33.96 earnings per share for the current year.

Key Headlines Impacting Elevance Health

Here are the key news stories impacting Elevance Health this week:

• Positive Sentiment: Q4 EPS beat — Elevance reported $3.33 EPS vs. the $3.10 consensus; the company cited rising premiums and strong Carelon (services) revenue as drivers. This beat is the main near-term bullish catalyst. Elevance Health Q4 Earnings Beat on Increasing Premiums
• Positive Sentiment: Revenue growth — Q4 revenue rose ~9.6% year-over-year to ~$49.3B, signaling durable top-line momentum even as membership trends and expense pressures vary. MarketBeat Q4 Results & Slide Deck
• Neutral Sentiment: Details & outlook context — The earnings call and transcripts provide color on membership trends, margin drivers and investments; investors will parse these to judge sustainability of the beat. Earnings Call Transcript
• Neutral Sentiment: Small revenue miss vs. consensus — Revenue of $49.31B was slightly under the $49.52B estimate; this tempers the beat and will keep attention on margin and membership details. What Key Metrics Have to Say
• Negative Sentiment: FY?2026 EPS guidance below Street — Elevance set FY?2026 EPS guidance that is below consensus, citing persistent higher medical costs; this is a clear downside risk to near-term estimates. Elevance forecasts 2026 profit below estimates
• Negative Sentiment: Policy/industry headwinds — Proposals to keep Medicare Advantage rates roughly flat have pressured the whole sector; that regulatory risk and comments about elevated medical costs have weighed on shares this week. Health insurers tumble after proposal to keep Medicare rates flat
• Negative Sentiment: Market reaction/short?term volatility — Analysts and press pieces flagged Medicare and margin risks, prompting near-term selling pressure earlier in the week despite today’s rebound. Barron’s: Why Earnings Are Adding to Medicare Pain

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.